Abstract:Background:Previous studies have confirmed that choline exerts anti-fibrotic effect in the heart by activating the M3 subtype of muscarinic acetylcholine receptor (M3 receptor), but the mechanism remains to be clarified. MicroRNA-29b (miR-29b) plays an important role in the fibrotic process and can directly target collagen to resist myocardial fibrosis. This study investigated whether miR-29b is involved in the anti-fibrotic effect of activating M3 receptor.Methods:Proliferation of cardiac fibroblasts was induced by transforming growth factor (TGF)-β1 in vitro. The expression of miR-29b in cardiac fibroblasts was detected by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). Protein levels of collagens I, connective tissue growth factor (CTGF), α-smooth muscle actin (α-SMA) and beta-site app cleaving enzyme 1 (BACE1) were determined by Western blot analysis. Fibroblast-myofibroblast transition was identified by immunofluorescence staining. Proliferation and migration of cardiac fibroblasts as indicated by transwell and scratch assays.Results:The expression of miR-29b decreased when treated with TGF-β1 (P=0.0389) and increased after choline stimulated (P=0.0001). Overexpression of miR-29b could reverse the high expression of collagen I (P<0.0001), α-SMA (P=0.0007), and CTGF (P=0.0038) induced by TGF-β1, whereas inhibition of miR-29b had a tendency to even further increase the expression of fibrosis markers. Meanwhile, inhibition of miR-29b could reverse the anti-fibrotic effect of choline, increasing the expression of collagen I (P=0.0040), α-SMA (P=0.0001), and CTGF (P=0.0185), and promoting the fibroblast proliferation and migration. Moreover, BACE1 protein level, increased after TGF-β1 treatment (P=0.0037) and reversed by overexpression of miR-29b (P=0.0493). Choline could reduce the increase of BACE1 induced by TGF-β1 (P=0.0264), and 4-diphenylacetoxy-N-methyl-piperidine methiodide (4-DAMP) increased the expression of BACE1 (P=0.0060). Furthermore, overexpression of BACE1 could reverse the protective effect of miR-29b in cardiac fibrosis, increasing the protein level of collagen I (P=0.0404).Conclusions:The results suggested that M3 receptor activation could exert cardioprotective effects in cardiac fibrosis by mediating miR-29b/BACE1 axis.

M3 Muscarinic Acetylcholine Receptor Dysfunction Inhibits Rac1 Activity and Disrupts VE-cadherin/β-catenin and Actin Cytoskeleton Interaction

Type 3 Muscarinic Acetylcholine Receptor Stimulation is a Determinant of Endothelial Barrier Function and Adherens Junctions Integrity: Role of Protein-Tyrosine Phosphatase 1B.

Methyltransferase Like 3-Mediated N6-methylatidin Methylation Inhibits Vascular Smooth Muscle Cells Phenotype Switching Via Promoting Phosphatidylinositol 3-Kinase Mrna Decay.

Effects of M3 muscarinic acetylcholine receptor on alpha smooth muscle-actin expression in cardiac fibroblasts and associated mechanism

Balanced Rac1 activity controls formation and maintenance of neuromuscular acetylcholine receptor clusters.

Roles of M 3 receptor in the effect of penehyclidine hydrochloride upregulated beta-arrestin-1 expression in LPS-stimulated HPMVEC.

Activation of M3 cholinoceptors attenuates vascular injury after ischaemia/reperfusion by inhibiting the Ca(2+) /calmodulin-dependent protein kinase II pathway.

M-3 Subtype Of Muscarinic Acetylcholine Receptor Promotes Cardioprotection Via The Suppression Of Mir-376b-5p

M3-R/IK(M3)--a New Target of Antiarrhythmic Agents.

M1 Muscarinic Receptors Regulate the Phosphorylation of AMPA Receptor Subunit GluA1 Via a Signaling Pathway Linking Camp‐pka and PI3K‐Akt

Effects of m3 muscarinic acetylcholine receptor on collagen type Ⅰ expression and associated mechanism in vascular smooth muscle cells

M3 Subtype of Muscarinic Acetylcholine Receptor Inhibits Cardiac Fibrosis Via Targeting Microrna-29B/beta-site App Cleaving Enzyme 1 Axis.

Abstract 3142: Pik3c3 Safeguards Smooth Muscle Identity by Promoting Lysosome-mediated Yap1 Degradation

The Role of Muscarinic Acetylcholine Receptor M3 in Cardiovascular Diseases

Activation Of M3achr (Type 3 Muscarinic Acetylcholine Receptor) And Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling By Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching And Vascular Remodeling

VAMP3 and SNAP23 Mediate the Disturbed Flow-Induced Endothelial Microrna Secretion and Smooth Muscle Hyperplasia.

M3 receptor is involved in the effect of penehyclidine hydrochloride reduced endothelial injury in LPS-stimulated human pulmonary microvascular endothelial cell.

Regulation of the Muscarinic M3 Receptor by Myocardin-Related Transcription Factors

Anisodine Hydrobromide Alleviates Oxidative Stress Caused by Hypoxia/reoxygenation in Human Cerebral Microvascular Endothelial Cells Predominantly Via Inhibition of Muscarinic Acetylcholine Receptor 4

M 3 receptor modulates extracellular matrix synthesis via ERK1/2 signaling pathway in human bladder smooth muscle cells.

[M3 Muscarnic Receptor Antagonist Mediates Cell Proliferation Apoptosis and Adhesion in Small Cell Lung Cancer].